The more important event in the last 1.5 month is the fact that the shorts are taking their profits and leaving the stock.They walked it down on competition fears and now it was the right time to get out.
as per deadline hollywood sunday am,"IMAX set a new benchmark with 48M globally and collected record breaking recepts in the UK France Germany Italy Japan Russia and Australia"
I just got an email from mr Liles at CLDK. here are his words:while we had not announced that we were presenting at the Openhimer Healthcare we were on their list.
Not presenting was a scheduling decision ---weaewat two conferences next week, the Guggenheim Boston health care day abd Roth Immuno-oncology day
I doubt that after the cc any institution is selling. NVDQ will be profitable in 2016 no real competition in sight and marketing expenses will be kept at current level, so if you hold it up to now why sell? The only institution to sell is the one who holds a short position as well that's why the price stayed at 10.9 for 30 min to my opinion.